Article
Fabry disease: a new approach for the screening of females in high-risk groups.
Clinical biochemistry - 1 May 2014
Pasqualim Gabriela, Simon Laura, Sperb-Ludwig Fernanda, Burin Maira Graef, Michelin-Tirelli Kristiane, Giugliani Roberto, Matte Ursula
Abstract excerpt
OBJECTIVE: Fabry disease (FD) is a rare X-linked inborn error of metabolism caused by deficient activity of lysosomal α-galactosidase A (α-GAL). Due to random X inactivation, α-GAL activity in heterozygous females ranges from very low to overlapping normal values. Determining this specific range and altering assays cutoffs could become a valuable tool for minimizing the need in DNA sequencing for screening of all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
